[Federal Register Volume 73, Number 202 (Friday, October 17, 2008)]
[Notices]
[Page 61909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-24768]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 10, 2008, Penick 
Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, 
made application by letter to the Drug Enforcement Administration (DEA) 
as a bulk manufacturer of Oripavine (9330), a basic class of controlled 
substance listed in schedule II.
    The company will use the above listed controlled substance in the 
manufacture of other controlled substance intermediates for sale to its 
customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 16, 2008.

    Dated: October 9, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-24768 Filed 10-16-08; 8:45 am]
BILLING CODE 4410-09-P